Meeting of the Drug Control Research, Data, and Evaluation Advisory Committee

---
identifier: "/us/fr/04-21327"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Meeting of the Drug Control Research, Data, and Evaluation Advisory Committee"
title_number: 0
title_name: "Federal Register"
section_number: "04-21327"
section_name: "Meeting of the Drug Control Research, Data, and Evaluation Advisory Committee"
positive_law: false
currency: "2004-09-23"
last_updated: "2004-09-23"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Office of National Drug Control Policy"
document_number: "04-21327"
document_type: "notice"
publication_date: "2004-09-23"
agencies:
  - "Office of National Drug Control Policy"
fr_citation: "69 FR 57099"
fr_volume: 69
comments_close_date: "2004-10-27"
fr_action: "Notice of meeting."
---


#  Meeting of the Drug Control Research, Data, and Evaluation Advisory Committee

**AGENCY:**

Office of National Drug Control Policy.

**ACTION:**

Notice of meeting.

**SUMMARY:**

The Drug Control Research, Data, and Evaluation Advisory Committee will meet to conduct ordinary business including discussions concerning the long-term and short-term planning for potential research projects.

**DATES:**

The meeting will be held Wednesday, October 27, 2004 from 10 a.m. to 5 p.m. and Thursday, October 28, 2004 from 9 a.m. to 5 p.m. There will be an opportunity for public comment from 4:30 p.m. to 5 p.m. on Wednesday, October 27, 2004.

**ADDRESSES:**

The meeting will be held at the Office of National Drug Control Policy, 750 17th Street, NW., 5th Floor Conference Room, Washington, DC.

**FOR FURTHER INFORMATION CONTACT:**

Janie Dargan, (202) 395-6714.

Dated: September 17, 2004.

Daniel R. Petersen,

Assistant General Counsel.